Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,707.8 | 130.03 | 4,09,650.46 | 1,181.05 | 0.79 | 5,985.33 | 98.33 |
Divis Laboratories Ltd DIVISLAB | 6,452.5 | 77.53 | 1,71,259.09 | 667 | 0.46 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,454.4 | 23.85 | 1,17,471.3 | 1,485.4 | 1.1 | 4,254.47 | 397.44 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,241.5 | 60.17 | 1,09,764.77 | 474 | 0.99 | 2,385 | 222.38 |
Mankind Pharma Ltd MANKIND | 2,549.2 | 54.42 | 1,05,236.41 | 416.38 | 0 | 2,396.57 | 334.17 |
The inspection was conducted from March 10 to March 13 of 2025 at Plot No. 5, GIDC, Panoli, Gujarat facility.
EBITDA at the operating level jumped 14.1% to ₹254.5 crore from ₹223.1 crore in the same quarter last year.
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
